Chadi Nabhan
Chadi Nabhan is an expert in Oncology at University of South Carolina (United States). As of October 2026, ScienceLeadR ranks Chadi Nabhan in the top 1% of experts worldwide for Lymphoproliferative Disorders. Chadi Nabhan has authored 426 publications, the most recent in 2026, and is an investigator in 16 clinical trials. SLR score: 1,762 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Urology - Genetics - Hematology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2001 - 2026
Number : 426
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Beyond Tumor Size, Toward Meaningful Patient Outcomes-Resisting RECIST. PMID 42848364 — neoplasms, response evaluation criteria in solid tumors | JAMA Oncol | 2026 | 0 |
| Prostate Cancer Treatments-Do The Dollars Create Value? PMID 42720956 — neoplasms, prostate, clinical medicine, prostatic neoplasms, therapeutics | JAMA Netw Open | 2026 | 0 |
| When TNM Staging Is Not Sufficient. PMID 42530898 — neoplasms | JAMA Oncol | 2026 | 0 |
| Magnetic Resonance Imaging-Based Staging in Prostate Cancer-Are We Ready? PMID 42455575 — neoplasms, prostate, magnetic resonance imaging, prostatic neoplasms | JAMA Netw Open | 2026 | 1 |
| Should We Call Every Cancer a Rare Cancer? PMID 42202241 — neoplasms, medical oncology | J Clin Oncol Top journal | 2026 | 0 |
Clinical Studies 16
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
LeadR Networks
Main global connection map